Takipte meme karsinomunda radyolojik algoritma nasıl olmalı?

Öz

Meme kanseri hastalarının radyolojik takibi, tedavi süreci boyunca ve sonrasında nüks, metastaz ve tedaviye bağlı komplikasyonların erken tespit edilmesi açısından büyük önem taşımaktadır. Bu bölümde, meme kanseri hastalarının takibinde radyolojik yaklaşım; neoadjuvan kemoterapi sürecinde tedaviye yanıtın değerlendirilmesi ve postoperatif memenin izlenmesi olmak üzere iki ana başlık altında ele alınmıştır.

Anahtar Kelimeler

• Meme kanseri
• ultrasonografi
• mamografi
• meme MR

What Should the Radiologic Follow-Up Algorithm Be for Breast Carcinoma?

Öz

Radiologic follow-up of breast cancer patients is of critical importance for the early detection of recurrence, metastasis, and treatment-related complications during and after the treatment process. In this section, the radiologic approach to follow-up in breast cancer patients is discussed under two main headings: assessment of treatment response during neoadjuvant chemotherapy and surveillance of the postoperative breast.

Anahtar Kelimeler

• Breast cancer
• ultrasonography
• mamography
• breast MRI

Kaynakça

1. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023;21(6):594-608.
2. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(5):331-357.
3. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.
4. Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Lu Y, Esserman LJ, et al. Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer. Radiology. 2018;289(3):618-626.
5. Houssami N, Macaskill P, Marinovich ML, et al. Meta-analysis of the accuracy of MRI for detecting residual breast cancer after neoadjuvant therapy. Ann Surg. 2013;257(2):249-255.
6. Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21(3):704-716.
7. Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, et al. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 2016;23(12):3801-3810.
8. Loibl S, André F, Bachelot T, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2024 update). Ann Oncol. 2024;35(2):159-182.

9. Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapy for early breast cancer: the St. Gallen International Consensus Conference 2023. Ann Onol. 2023;34(7):573-589.